These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

239 related items for PubMed ID: 26772819

  • 1. Anti-inflammatory therapies in TRAMP mice: delay in PCa progression.
    Kido LA, Montico F, Sauce R, Macedo AB, Minatel E, Costa DB, Carvalho JE, Pilli RA, Cagnon VH.
    Endocr Relat Cancer; 2016 Apr; 23(4):235-50. PubMed ID: 26772819
    [Abstract] [Full Text] [Related]

  • 2. Steroidal hormone and morphological responses in the prostate anterior lobe in different cancer grades after Celecoxib and Goniothalamin treatments in TRAMP mice.
    Silva RS, Kido LA, Montico F, Vendramini-Costa DB, Pilli RA, Cagnon VHA.
    Cell Biol Int; 2018 Aug; 42(8):1006-1020. PubMed ID: 29603508
    [Abstract] [Full Text] [Related]

  • 3. Goniothalamin and Celecoxib Effects During Aging: Targeting Pro-Inflammatory Mediators in Chemoprevention of Prostatic Disorders.
    Kido LA, Montico F, Vendramini-Costa DB, Pilli RA, Cagnon VHA.
    Prostate; 2017 Jun; 77(8):838-848. PubMed ID: 28191652
    [Abstract] [Full Text] [Related]

  • 4. Association of anti-inflammatory and antiangiogenic therapies negatively influences prostate cancer progression in TRAMP mice.
    Mateus PAM, Kido LA, Silva RS, Cagnon VHA, Montico F.
    Prostate; 2019 Apr; 79(5):515-535. PubMed ID: 30585351
    [Abstract] [Full Text] [Related]

  • 5. Regression of mouse prostatic intraepithelial neoplasia by nonsteroidal anti-inflammatory drugs in the transgenic adenocarcinoma mouse prostate model.
    Narayanan BA, Narayanan NK, Pittman B, Reddy BS.
    Clin Cancer Res; 2004 Nov 15; 10(22):7727-37. PubMed ID: 15570007
    [Abstract] [Full Text] [Related]

  • 6. Adenocarcina of the mouse prostate growth inhibition by celecoxib: downregulation of transcription factors involved in COX-2 inhibition.
    Narayanan BA, Narayanan NK, Pttman B, Reddy BS.
    Prostate; 2006 Feb 15; 66(3):257-65. PubMed ID: 16175586
    [Abstract] [Full Text] [Related]

  • 7. Suppression of prostate carcinogenesis by dietary supplementation of celecoxib in transgenic adenocarcinoma of the mouse prostate model.
    Gupta S, Adhami VM, Subbarayan M, MacLennan GT, Lewin JS, Hafeli UO, Fu P, Mukhtar H.
    Cancer Res; 2004 May 01; 64(9):3334-43. PubMed ID: 15126378
    [Abstract] [Full Text] [Related]

  • 8. Oral grape seed extract inhibits prostate tumor growth and progression in TRAMP mice.
    Raina K, Singh RP, Agarwal R, Agarwal C.
    Cancer Res; 2007 Jun 15; 67(12):5976-82. PubMed ID: 17575168
    [Abstract] [Full Text] [Related]

  • 9. Lobe-specific responses of TRAMP mice dorsolateral prostate following celecoxib and nintedanib therapy.
    Montico F, Lamas CA, Rossetto IMU, Baseggio AM, Cagnon VHA.
    J Mol Histol; 2023 Aug 15; 54(4):379-403. PubMed ID: 37335420
    [Abstract] [Full Text] [Related]

  • 10. Nintedanib antiangiogenic inhibitor effectiveness in delaying adenocarcinoma progression in Transgenic Adenocarcinoma of the Mouse Prostate (TRAMP).
    da Silva RF, Nogueira-Pangrazi E, Kido LA, Montico F, Arana S, Kumar D, Raina K, Agarwal R, Cagnon VHA.
    J Biomed Sci; 2017 May 12; 24(1):31. PubMed ID: 28499383
    [Abstract] [Full Text] [Related]

  • 11. Epigallocatechin-3-Gallate suppresses early stage, but not late stage prostate cancer in TRAMP mice: mechanisms of action.
    Harper CE, Patel BB, Wang J, Eltoum IA, Lamartiniere CA.
    Prostate; 2007 Oct 01; 67(14):1576-89. PubMed ID: 17705241
    [Abstract] [Full Text] [Related]

  • 12. Dietary feeding of silibinin inhibits prostate tumor growth and progression in transgenic adenocarcinoma of the mouse prostate model.
    Raina K, Blouin MJ, Singh RP, Majeed N, Deep G, Varghese L, Glodé LM, Greenberg NM, Hwang D, Cohen P, Pollak MN, Agarwal R.
    Cancer Res; 2007 Nov 15; 67(22):11083-91. PubMed ID: 18006855
    [Abstract] [Full Text] [Related]

  • 13. Transgenic Adenocarcinoma of the Mouse Prostate (TRAMP) model: A good alternative to study PCa progression and chemoprevention approaches.
    Kido LA, de Almeida Lamas C, Maróstica MR, Cagnon VHA.
    Life Sci; 2019 Jan 15; 217():141-147. PubMed ID: 30528182
    [Abstract] [Full Text] [Related]

  • 14. Loss of MyD88 leads to more aggressive TRAMP prostate cancer and influences tumor infiltrating lymphocytes.
    Peek EM, Song W, Zhang H, Huang J, Chin AI.
    Prostate; 2015 Apr 01; 75(5):463-73. PubMed ID: 25597486
    [Abstract] [Full Text] [Related]

  • 15. Constitutive activation of P I3 K-Akt and NF-kappaB during prostate cancer progression in autochthonous transgenic mouse model.
    Shukla S, Maclennan GT, Marengo SR, Resnick MI, Gupta S.
    Prostate; 2005 Aug 01; 64(3):224-39. PubMed ID: 15712212
    [Abstract] [Full Text] [Related]

  • 16. Prostatic angiogenic responses in late life: antiangiogenic therapy influences and relation with the glandular microenvironment in the transgenic adenocarcinoma of mouse prostate (TRAMP) model.
    Montico F, Kido LA, Hetzl AC, Cagnon VH.
    Prostate; 2015 Apr 01; 75(5):484-99. PubMed ID: 25521760
    [Abstract] [Full Text] [Related]

  • 17. Chemopreventive and bioenergetic signaling effects of PDK1/Akt pathway inhibition in a transgenic mouse model of prostate cancer.
    Sargeant AM, Klein RD, Rengel RC, Clinton SK, Kulp SK, Kashida Y, Yamaguchi M, Wang X, Chen CS.
    Toxicol Pathol; 2007 Jun 01; 35(4):549-61. PubMed ID: 17562488
    [Abstract] [Full Text] [Related]

  • 18. Efficacious chemoprevention of primary prostate cancer by flutamide in an autochthonous transgenic model.
    Raghow S, Kuliyev E, Steakley M, Greenberg N, Steiner MS.
    Cancer Res; 2000 Aug 01; 60(15):4093-7. PubMed ID: 10945615
    [Abstract] [Full Text] [Related]

  • 19. Dietary methionine restriction inhibits prostatic intraepithelial neoplasia in TRAMP mice.
    Sinha R, Cooper TK, Rogers CJ, Sinha I, Turbitt WJ, Calcagnotto A, Perrone CE, Richie JP.
    Prostate; 2014 Dec 01; 74(16):1663-73. PubMed ID: 25250521
    [Abstract] [Full Text] [Related]

  • 20. Nintedanib treatment delays prostate dorsolateral lobe cancer progression in the TRAMP model: contribution to the epithelial-stromal interaction balance.
    Nogueira Pangrazi E, da Silva RF, Kido LA, Montico F, Cagnon VHA.
    Cell Biol Int; 2018 Feb 01; 42(2):153-168. PubMed ID: 28980742
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.